Metabolic complications of obesity

被引:169
作者
Grundy, SM
机构
[1] Univ Texas, SW Med Ctr, Dept Clin Nutr, Ctr Human Nutr, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Ctr Human Nutr, Dallas, TX 75390 USA
关键词
metabolic syndrome; insulin resistance; obesity; metabolic complications;
D O I
10.1385/ENDO:13:2:155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The rising prevalence of obesity is accompanied by an increasing number of patients with the metabolic complications of obesity. The major complications come under the heading of the metabolic syndrome. This syndrome is characterized by plasma lipid disorders (atherogenic dyslipidemia), raised blood pressure, elevated plasma glucose, and a prothrombotic state. The clinical consequences of the metabolic syndrome are coronary heart disease and stroke, type 2 diabetes and its complications, fatty liver, cholesterol gallstones, and possibly some forms of cancer, At the heart of the metabolic syndrome is insulin resistance, which represents a generalized derangement in metabolic processes. Obesity is the predominant factor leading to insulin resistance, although other factors play a role, The mechanistic link between insulin resistance and the metabolic syndrome is complex. The relationship is modulated by yet other factors, such as physical activity, body fat distribution, hormones, and a person's genetic polymorphic architecture. A better understanding of the molecular basis of this relationship is needed to suggest new targets for prevention and treatment of the complications of obesity. In addition, understanding at the clinical level will lead to improved management of these complications.
引用
收藏
页码:155 / 165
页数:11
相关论文
共 111 条
  • [1] RELATIONSHIPS OF GENERALIZED AND REGIONAL ADIPOSITY TO INSULIN SENSITIVITY IN MEN
    ABATE, N
    GARG, A
    PESHOCK, RM
    STRAYGUNDERSEN, J
    GRUNDY, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 88 - 98
  • [2] Baraona E, 1998, RECENT DEV ALCOHOL, V14, P97, DOI 10.1007/0-306-47148-5_5
  • [3] Bjorntorp P, 1996, INT J OBESITY, V20, P291
  • [4] BJORNTORP P, 1985, ANN CLIN RES, V17, P3
  • [5] MECHANISMS OF FATTY ACID-INDUCED INHIBITION OF GLUCOSE-UPTAKE
    BODEN, G
    CHEN, XH
    RUIZ, J
    WHITE, JV
    ROSSETTI, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) : 2438 - 2446
  • [6] Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169
  • [7] RELATIONSHIP BETWEEN OBESITY AND MAXIMAL INSULIN-STIMULATED GLUCOSE-UPTAKE INVIVO AND INVITRO IN PIMA-INDIANS
    BOGARDUS, C
    LILLIOJA, S
    MOTT, D
    REAVEN, GR
    KASHIWAGI, A
    FOLEY, JE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) : 800 - 805
  • [8] SITE DIFFERENCES IN INSULIN-RECEPTOR BINDING AND INSULIN ACTION IN SUBCUTANEOUS FAT OF OBESE FEMALES
    BOLINDER, J
    ENGFELDT, P
    OSTMAN, J
    ARNER, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (03) : 455 - 461
  • [9] Chronic exposure to free fatty acid reduces pancreatic β cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation
    Bollheimer, LC
    Skelly, RH
    Chester, MW
    McGarry, JD
    Rhodes, CJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) : 1094 - 1101
  • [10] THE MOLECULAR MECHANISM FOR THE ASSEMBLY AND SECRETION OF APO-B-100-CONTAINING LIPOPROTEINS
    BOREN, J
    WHITE, A
    WETTESTEN, M
    SCOTT, J
    GRAHAM, L
    OLOFSSON, SO
    [J]. PROGRESS IN LIPID RESEARCH, 1991, 30 (2-3) : 205 - 218